Literature DB >> 19435396

Improving laboratory monitoring of medications: an economic analysis alongside a clinical trial.

David H Smith1, Adrianne C Feldstein, Nancy A Perrin, Xiuhai Yang, Mary M Rix, Marsha A Raebel, David J Magid, Steven R Simon, Stephen B Soumerai.   

Abstract

OBJECTIVE: To test the efficiency and cost-effectiveness of interventions aimed at enhancing laboratory monitoring of medication. STUDY
DESIGN: Cost-effectiveness analysis.
METHODS: Patients of a not-for-profit, group-model HMO were randomized to 1 of 4 interventions: an electronic medical record reminder to the clinician, an automated voice message to patients, pharmacy-led outreach, or usual care. Patients were followed for 25 days to determine completion of all recommended baseline laboratory monitoring tests. We measured the rate of laboratory test completion and the cost-effectiveness of each intervention. Direct medical care costs to the HMO (repeated testing, extra visits, and intervention costs) were determined using trial data and a mix of other data sources.
RESULTS: The average cost of patient contact was $5.45 in the pharmacy-led intervention, $7.00 in the electronic reminder intervention, and $4.64 in the automated voice message reminder intervention. The electronic medical record intervention was more costly and less effective than other methods. The automated voice message intervention had an incremental cost-effectiveness ratio (ICER) of $47 per additional completed case, and the pharmacy intervention had an ICER of $64 per additional completed case.
CONCLUSIONS: Using the data available to compare strategies to enhance baseline monitoring, direct clinician messaging was not an efficient use of resources. Depending on a decision maker's willingness to pay, automated voice messaging and pharmacy-led efforts can be efficient choices to prompt therapeutic baseline monitoring, but direct clinician messaging is probably a less efficient use of resources.

Entities:  

Mesh:

Year:  2009        PMID: 19435396

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  11 in total

Review 1.  A review of the methodological challenges in assessing the cost effectiveness of pharmacist interventions.

Authors:  Rachel A Elliott; Koen Putman; James Davies; Lieven Annemans
Journal:  Pharmacoeconomics       Date:  2014-12       Impact factor: 4.981

2.  A real-world cohort study on the quality of potassium and creatinine monitoring during initiation of mineralocorticoid receptor antagonists in patients with heart failure.

Authors:  Erik Nilsson; Pietro De Deco; Marco Trevisan; Rino Bellocco; Bengt Lindholm; Lars H Lund; Josef Coresh; Juan J Carrero
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2018-10-01

3.  Noninterruptive Clinical Decision Support Decreases Ordering of Respiratory Viral Panels during Influenza Season.

Authors:  Cameron Escovedo; Douglas Bell; Eric Cheng; Omai Garner; Alyssa Ziman; Sitaram Vangala; Prabhu Gounder; Carlos Lerner
Journal:  Appl Clin Inform       Date:  2020-04-29       Impact factor: 2.342

4.  Beyond the prescription: medication monitoring and adverse drug events in older adults.

Authors:  Michael A Steinman; Steven M Handler; Jerry H Gurwitz; Gordon D Schiff; Kenneth E Covinsky
Journal:  J Am Geriatr Soc       Date:  2011-07-28       Impact factor: 5.562

5.  Guideline concordance of testing for hyperkalemia and kidney dysfunction during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure.

Authors:  Larry A Allen; Susan M Shetterly; Pamela N Peterson; Jerry H Gurwitz; David H Smith; David W Brand; Diane L Fairclough; John S Rumsfeld; Frederick A Masoudi; David J Magid
Journal:  Circ Heart Fail       Date:  2013-11-26       Impact factor: 8.790

Review 6.  Drug-Related Hospital Visits and Admissions Associated with Laboratory or Physiologic Abnormalities-A Systematic-Review.

Authors:  Kerry Wilbur; Huda Hazi; Aya El-Bedawi
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

Review 7.  Can computerized clinical decision support systems improve practitioners' diagnostic test ordering behavior? A decision-maker-researcher partnership systematic review.

Authors:  Pavel S Roshanov; John J You; Jasmine Dhaliwal; David Koff; Jean A Mackay; Lorraine Weise-Kelly; Tamara Navarro; Nancy L Wilczynski; R Brian Haynes
Journal:  Implement Sci       Date:  2011-08-03       Impact factor: 7.327

Review 8.  Computerized clinical decision support systems for drug prescribing and management: a decision-maker-researcher partnership systematic review.

Authors:  Brian J Hemens; Anne Holbrook; Marita Tonkin; Jean A Mackay; Lorraine Weise-Kelly; Tamara Navarro; Nancy L Wilczynski; R Brian Haynes
Journal:  Implement Sci       Date:  2011-08-03       Impact factor: 7.327

9.  Automated telephone calls to enhance colorectal cancer screening: economic analysis.

Authors:  David H Smith; Adrienne C Feldstein; Nancy Perrin; A Gabriela Rosales; David M Mosen; Elizabeth G Liles; Jennifer L Schneider; Jennifer E Lafata; Ronald E Meyers; Russell E Glasgow
Journal:  Am J Manag Care       Date:  2012-11       Impact factor: 2.229

10.  Interventions to Educate Family Physicians to Change Test Ordering: Systematic Review of Randomized Controlled Trials.

Authors:  Roger Edmund Thomas; Marcus Vaska; Christopher Naugler; Tanvir Turin Chowdhury
Journal:  Acad Pathol       Date:  2016-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.